DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
+13.89%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$372M
AUM Growth
+$372M
(+1.3%)
Cap. Flow
-$24.6M
Cap. Flow
% of AUM
-6.63%
Top 10 Holdings %
Top 10 Hldgs %
47.82%
Holding
98
New
8
Increased
10
Reduced
34
Closed
10
Top Buys
| 1 |
Revolution Medicines
RVMD
|
$3.55M |
| 2 |
MediWound
MDWD
|
$1.99M |
| 3 |
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
|
$1.71M |
| 4 |
Larimar Therapeutics
LRMR
|
$1.68M |
| 5 |
Kura Oncology
KURA
|
$1.21M |
Top Sells
| 1 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$7.46M |
| 2 |
NTUS
Natus Medical Inc
NTUS
|
$4.71M |
| 3 |
SPDR S&P Biotech ETF
XBI
|
$3.73M |
| 4 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
$3.65M |
| 5 |
Xenon Pharmaceuticals
XENE
|
$2.29M |
Sector Composition
| 1 | Healthcare | 81.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Century Therapeutics
IPSC
$40.4M
| $4.7M | 1.26% |
475,367
| – | – |
|
27
Arcus Biosciences
RCUS
$1.24B
| $4.68M | 1.26% |
178,717
-9,000
| -5% | -$235K |
|
|
AERI
28
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $4.65M | 1.25% |
307,232
+18,192
| +6% | +$275K |
|
29
Apellis Pharmaceuticals
APLS
$3.51B
| $4.5M | 1.21% |
65,946
-30,989
| -32% | -$2.12M |
|
|
CSII
30
DELISTED
Cardiovascular Systems, Inc.
CSII
| $3.98M | 1.07% |
286,988
| – | – |
|
31
Axogen
AXGN
$718M
| $3.96M | 1.06% |
332,103
| – | – |
|
32
89bio
ETNB
$1.37B
| $3.79M | 1.02% |
654,862
-111,912
| -15% | -$648K |
|
33
KalVista Pharmaceuticals
KALV
$713M
| $3.71M | 1% |
255,313
-10,350
| -4% | -$150K |
|
|
FSTX
34
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $2.95M | 0.79% |
576,881
| – | – |
|
|
BCYC
35
Bicycle Therapeutics
BCYC
$492M
| $2.84M | 0.76% |
122,200
-9,000
| -7% | -$209K |
|
|
36
Kura Oncology
KURA
$732M
| $2.82M | 0.76% |
206,329
+88,500
| +75% | +$1.21M |
|
37
AtriCure
ATRC
$1.73B
| $2.82M | 0.76% |
72,029
| – | – |
|
38
Mersana Therapeutics
MRSN
$34.8M
| $2.55M | 0.69% |
377,763
-29,000
| -7% | -$196K |
|
|
39
MediWound
MDWD
$180M
| $1.99M | 0.53% |
+1,428,571
| New | +$1.99M |
|
|
VIGL
40
DELISTED
Vigil Neuroscience
VIGL
| $1.97M | 0.53% |
216,395
+116,641
| +117% | +$1.06M |
|
41
Accuray
ARAY
$165M
| $1.96M | 0.53% |
941,800
| – | – |
|
|
ITOS
42
DELISTED
iTeos Therapeutics
ITOS
| $1.86M | 0.5% |
97,560
-7,738
| -7% | -$147K |
|
|
43
Larimar Therapeutics
LRMR
$337M
| $1.84M | 0.49% |
574,996
+525,000
| +1,050% | +$1.68M |
|
44
Galapagos
GLPG
$2.06B
| $1.82M | 0.49% |
42,675
| – | – |
|
|
SYRS
45
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $1.71M | 0.46% |
+265,878
| New | +$1.71M |
|
|
DICE
46
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $1.59M | 0.43% |
78,500
-78,404
| -50% | -$1.59M |
|
47
Viking Therapeutics
VKTX
$3.02B
| $1.5M | 0.4% |
552,400
+90,000
| +19% | +$245K |
|
48
Keros Therapeutics
KROS
$640M
| $1.47M | 0.39% |
39,000
| – | – |
|
|
AFMD
49
DELISTED
Affimed
AFMD
| $1.41M | 0.38% |
686,282
| – | – |
|
50
Oric Pharmaceuticals
ORIC
$1.03B
| $1.32M | 0.36% |
413,526
-2,400
| -0.6% | -$7.68K |
|